Recombinant Human NBL1 protein (rFc Tag)(HPLC verified)
种属
Human
纯度
>90 %, SDS-PAGE
>90 %, SEC-HPLC
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
| 纯度 | >90 %, SDS-PAGE >90 %, SEC-HPLC |
| 内毒素 | <0.1 EU/μg protein, LAL method |
| 生物活性 |
Not tested |
| 来源 | HEK293-derived Human NBL1 protein Ala17-Asp181 (Accession# P41271-1) with a rabbit IgG Fc tag at the C-terminus. |
| 基因ID | 4681 |
| 蛋白编号 | P41271-1 |
| 预测分子量 | 43.7 kDa |
| SDS-PAGE | 45-55 kDa, reducing (R) conditions |
| 组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| 复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| 储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
NBL1 (neuroblastoma suppression of tumorigenicity 1), also named as DAN, is the founding member of the DAN subfamily. It was originally identified as a putative tumor suppressor gene in a transformed fibroblast rat model, whereby it was significantly down-regulated in v-src-transformed rat fibroblasts. The MW of this protein is 19 kDa, and this antibody specially recognises the 19 kDa protein.
参考文献:
1. Tsai CH. et al. (2023) Biomolecules. 13(11):1570. 2. Ladenstein R. et al. (2018) Lancet Oncol. 19(12):1617-1629. 3. Lu L. et al. (2022) Oncogenesis. 11(1):21. 4. Du J. et al. (2023) Thorac Cancer. 14(30):3032-3041. 5. Wang A. et al. (2022) Parasitol Res. 121(5):1369-1378.

